secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adaptive Biotechnologies Corp (ADPT)
CIK:        0001478320
Form:       8-K
Filed at:   2022-03-11T23:59:59+00:00
Accession:  0001564590-22-009876
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Adaptive Biotechnologies appoints Tycho Peterson as CFO
-------------------------------------------------------

- Appointed Tycho Peterson as CFO effective on or before June 4, 2022; will serve as principal financial officer.
- Annual salary of $425,000, plus annual incentive opportunity of 50% of salary, prorated for 2022.
- Equity grants: 374,688 RSUs (4-yr vest) and 597,157 stock options (4-yr vest).
- Previously Managing Director at J.P. Morgan; holds MBA from Oxford and BA from Cornell.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478320/000156459022009876/0001564590-22-009876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478320/000156459022009876/adpt-8k_20220309.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-009876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer